1. Metformin Enhances Nomegestrol Acetate Suppressing Growth of Endometrial Cancer Cells and May Correlate to Downregulating mTOR Activity In Vitro and In Vivo
   Can Cao et al, 2019, International Journal of Molecular Sciences CrossRef
2. Incretin-based therapy for the treatment of bone fragility in diabetes mellitus
   Guillaume Mabilleau et al, 2018, Peptides CrossRef
3. Liraglutide Promotes Osteoblastic Differentiation in MC3T3-E1 Cells by ERK5 Pathway
   Yue Sun et al, 2020, International Journal of Endocrinology CrossRef
4. The Impact of Glucagon-Like Peptide-1 on Bone Metabolism and Its Possible Mechanisms
   Chenhe Zhao et al, 2017, Frontiers in Endocrinology CrossRef
5. Strontium promotes osteogenic differentiation by activating autophagy via the the AMPK/mTOR signaling pathway in MC3T3‑E1 cells
   You Cheng et al, 2019, International Journal of Molecular Medicine CrossRef
6. Liraglutide Attenuates Aortic Valve Calcification in a High-Cholesterol-Diet-Induced Experimental Calcific Aortic Valve Disease Model in Apolipoprotein E-Deficient Mice
   Yangzhao Zhou et al, 2023, Journal of Cardiovascular Development and Disease CrossRef
7. Effect of gut hormones on bone metabolism and their possible mechanisms in the treatment of osteoporosis
   Hongyu Liu et al, 2024, Frontiers in Pharmacology CrossRef
8. Exenatide Improves Bone Quality in a Murine Model of Genetically Inherited Type 2 Diabetes Mellitus
   Marie Pereira et al, 2017, Frontiers in Endocrinology CrossRef
9. Gut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis Treatment
   Sine Paasch Schiellerup et al, 2019, Frontiers in Endocrinology CrossRef
10. Vascular calcification: Molecular mechanisms and therapeutic interventions
    Wei Pan et al, 2023, MedComm CrossRef
11. Tongxinluo exerts protective effects via anti‐apoptotic and pro‐autophagic mechanisms by activating AMPK pathway in infarcted rat hearts
    Qing Li et al, 2017, Experimental Physiology CrossRef
12. MHY1485 activates mTOR and protects osteoblasts from dexamethasone
    Sai Zhao et al, 2016, Biochemical and Biophysical Research Communications CrossRef
13. MHY1485 ameliorates UV-induced skin cell damages via activating mTOR-Nrf2 signaling
    Bo Yang et al, 2017, Oncotarget CrossRef
14. mTOR Signaling Pathway in Bone Diseases Associated with Hyperglycemia
    Shuangcheng Wang et al, 2023, International Journal of Molecular Sciences CrossRef
15. Liraglutide Promotes the Osteogenic Differentiation in MC3T3-E1 Cells via Regulating the Expression of Smad2/3 Through PI3K/Akt and Wnt/β-Catenin Pathways
    Liu Gao et al, 2018, DNA and Cell Biology CrossRef
16. Dexamethasone suppresses osteogenesis of osteoblast via the PI3K/Akt signaling pathway in vitro and in vivo
    Ji-Ming Pan et al, 2019, Journal of Receptors and Signal Transduction CrossRef
17. Increased miR‐124‐3p in microglial exosomes following traumatic brain injury inhibits neuronal inflammation and contributes to neurite outgrowthviatheir transfer into neurons
    Shan Huang et al, 2018, The FASEB Journal CrossRef
18. Bone resorption is unchanged by liraglutide in type 2 diabetes patients: A randomised controlled trial
    Katrine Hygum et al, 2020, Bone CrossRef